Facemasks and Walk Distance in Pulmonary Arterial Hypertension Patients

Facemasks and Walk Distance in Pulmonary Arterial Hypertension Patients

Little is known about the effect of wearing a facemask on the physiological and perceptual responses to exercise in patients with pulmonary arterial hypertension (PAH). We performed a single-center retrospective study to evaluate whether facemask wearing impacted distanced covered, rating of perceiv...

Full description

Bibliographic Details
Main Authors:	Scott A. Helgeson, MD, Charles D. Burger, MD, John E. Moss, MD, Tonya K. Zeiger, RRT, Bryan J. Taylor, PhD
Format:	Article
Language:	English
Published:	Elsevier 2021-10-01
Series:	Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Online Access:	http://www.sciencedirect.com/science/article/pii/S2542454821001223

Similar Items

Twelve-Year Survival in a Patient With Systemic Sclerosis–Associated Pulmonary Arterial Hypertension on Nifedipine Monotherapy
by: Scott A. Helgeson, MD, et al.
Published: (2019-09-01)

Psychosocial and Financial Burden of Therapy in USA Patients with Pulmonary Arterial Hypertension
by: Scott A. Helgeson, et al.
Published: (2020-06-01)

Prevalence of Sodium and Fluid Restriction Recommendations for Patients with Pulmonary Hypertension
by: Tonya Zeiger, et al.
Published: (2015-07-01)

Facemask and social distancing, pillars of opening up economies.
by: Ali Najmi, et al.
Published: (2021-01-01)

Can a Six-Minute Walk Distance Predict Right Ventricular Dysfunction in Patients with Diffuse Parenchymal Lung Disease and Pulmonary Hypertension?
by: Kamonpun Ussavarungsi, et al.
Published: (2016-09-01)

Better Outcomes in Pulmonary Arterial Hypertension After Repair of Congenital Heart Disease, Compared With Idiopathic Pulmonary Arterial Hypertension
by: Zhuoyuan Xu, MM, et al.
Published: (2021-07-01)

Correction: Facemask and social distancing, pillars of opening up economies.
by: PLOS ONE Staff
Published: (2021-01-01)

Efficacy of Dabigatran in Pulmonary Embolism Due to Thrombophilia in Chronic Thromboembolic Pulmonary Hypertension∗
by: Saverio Muscoli, MD, PhD
Published: (2020-04-01)

Targeting Neurohormonal Activation in Pulmonary Arterial Hypertension
by: Jose Gomez-Arroyo, MD, PhD, et al.
Published: (2017-02-01)

Comparison of Brain Natriuretic Peptide Levels to Simultaneously Obtained Right Heart Hemodynamics in Stable Outpatients with Pulmonary Arterial Hypertension
by: Scott A. Helgeson, et al.
Published: (2018-05-01)

A case of balloon pulmonary angioplasty as a palliative therapy in chronic thromboembolic pulmonary hypertension
by: Georgios Sianos, MD, PhD, FESC, et al.
Published: (2016-09-01)

Pregnancy in a Patient With Tetralogy of Fallot and Borderline Pulmonary Arterial Hypertension
by: Alexandra A. Frogoudaki, MD, PhD, et al.
Published: (2020-01-01)

Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Initial Single-Center Experience
by: Vidhu Anand, MBBS, et al.
Published: (2019-09-01)

Indigenous neonatal facemask
by: Lalit Kumar Raiger
Published: (2010-01-01)

Pulmonary hypertension: The diagnostic and prognostic value of novel imaging techniques
by: Dimitris Tousoulis, MD, PhD
Published: (2020-03-01)

Fick principle and exercise pulmonary hemodynamic determinants of the six-minute walk distance in pulmonary hypertension
by: Phillip Joseph, et al.
Published: (2020-09-01)

Pulmonary arterial hypertension in congenital heart disease: Current perspectives and future challenges
by: George Giannakoulas, MD, PhD, et al.
Published: (2016-07-01)

Maximal cardiac output determines 6 minutes walking distance in pulmonary hypertension.
by: Gaël Deboeck, et al.
Published: (2014-01-01)

Natural History of Double Inlet Left Ventricle and Pulmonary Hypertension in an Adult Patient
by: Daniel Salame-Waxman, MD, et al.
Published: (2019-12-01)

4D-flow MRI assessment of blood flow before and after endovascular intervention in a patient with pulmonary hypertension due to isolated pulmonary artery involvement in large vessel vasculitis
by: Hiroki Kamada, MD, PhD, et al.
Published: (2020-03-01)

Comprehensive Review on Facemask Detection Techniques in the Context of Covid-19
by: Afsana Nowrin, et al.
Published: (2021-01-01)

A diffuse lung emphysema, severe pulmonary hypertension and lack of airflow limitation
by: Morgane Faure, MD, et al.
Published: (2017-01-01)

Pathogenic Role of mTORC1 and mTORC2 in Pulmonary Hypertension
by: Haiyang Tang, PhD, et al.
Published: (2018-12-01)

Outcomes of Liver Transplantation in Treated Portopulmonary Hypertension Patients With a Mean Pulmonary Arterial Pressure ≥35 mm Hg
by: Hilary M. DuBrock, MD, et al.
Published: (2020-12-01)

Pulmonary arterial hypertension and quality of life in cardiology. Do we really need more studies?
by: Dimitris Tousoulis, MD, PhD
Published: (2016-07-01)

Renal Denervation Reduces Pulmonary Vascular Remodeling and Right Ventricular Diastolic Stiffness in Experimental Pulmonary Hypertension
by: Denielli da Silva Gonçalves Bos, MSc, et al.
Published: (2017-02-01)

Hemodynamic Characteristics and Outcomes of Pulmonary Hypertension in Patients Undergoing Tricuspid Valve Repair or Replacement
by: Mahima Vijayaraghavan, MD, et al.
Published: (2021-04-01)

The need to move from 6-minute walk distance to outcome trials in pulmonary arterial hypertension
by: Sean Gaine, et al.
Published: (2013-12-01)

Directing Therapy in Pulmonary Arterial Hypertension Using a Target 6 Min Walk Distance
by: Nancy Rose Porhownik, et al.
Published: (2013-01-01)

A Randomized Study of Safety and Efficacy of Two Doses of Ambrisentan to Treat Pulmonary Arterial Hypertension in Pediatric Patients
by: Dunbar Ivy, MD, et al.
Published: (2020-01-01)

Facemasks: A Looming Microplastic Crisis
by: Janith Dissanayake, et al.
Published: (2021-07-01)

Treatment of Class III with Facemask Therapy
by: Snigdha Pattanaik, et al.
Published: (2016-01-01)

Expansion/Facemask Treatment of an Adult Class III Malocclusion
by: Gregory W. Jackson, et al.
Published: (2014-01-01)

The Significance of Pulmonary Artery Size in Pulmonary Hypertension
by: Kamonpun Ussavarungsi, et al.
Published: (2014-07-01)

Prognostic value of six-minute walk distance at a South American pulmonary hypertension referral center
by: Gabriela O.S. Costa, et al.
Published: (2020-05-01)

Chronic thromboembolic pulmonary hypertension is a clot you cannot swat
by: G. Jay Bishop, MD, FACP, FSVM, RPVI, et al.
Published: (2019-12-01)

Hip Fracture in a Patient With Severe Pulmonary Hypertension
by: Susan M. Friedman MD, MPH, et al.
Published: (2012-09-01)

Irregular wide QRS complex tachycardia in a patient with pulmonary hypertension: What is the mechanism?
by: Abigail Louise D. Te, MD, et al.
Published: (2016-01-01)

Spatial relationship between the pulmonary trunk and the left coronaries: Systematic risk assessment based on automated three-dimensional distance measurementsKey Findings
by: Eberhard Scholz, MD, PhD, et al.
Published: (2020-04-01)

Comparison of facemask characteristics with user assessment of comfort
by: Purdy, Matthew
Published: (2019)